The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The IKMB's core facilities received infrastructure support by the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Precision Medicine in Chronic Inflammation" (PMI, EXC2167). The project also received support through a philanthropic donation by Stein Erik Hagen and Canica AS.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The following ethical approvals of the project were obtained from the relevant ethics committees: Germany: Kiel (reference number D464/20); Italy: Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico (reference number 342_2020 and 334-2020 for cases and controls, respectively), Humanitas Clinical and Research Center, IRCCS (reference number 316/20), San Gerardo Hospital School of Medicine, Monza (the ethics committee of the National Institute of Infectious Diseases Lazzarro Spallanzani reference number 84/2020); Norway: Regional Committee for Medical and Health Research Ethics in South-Eastern Norway (reference number 132550); Spain: Hospital Clinic and IDIBAPS, Barcelona (reference number HCB/2020/0405), Hospital Universitario Vall d'Hebron, Barcelona (reference PR[AG]244/2020), Hospital Universitario Ramon y Cajal, Madrid (reference number 093/20), Donostia University Hospital, San Sebastian (reference number PI2020064).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes